4,176 Shares in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Purchased by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. bought a new stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 4,176 shares of the real estate investment trust’s stock, valued at approximately $78,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Janney Montgomery Scott LLC boosted its position in shares of Sabra Health Care REIT by 8.8% in the first quarter. Janney Montgomery Scott LLC now owns 176,182 shares of the real estate investment trust’s stock valued at $2,602,000 after acquiring an additional 14,198 shares during the period. Texas Permanent School Fund Corp increased its holdings in shares of Sabra Health Care REIT by 1.4% in the first quarter. Texas Permanent School Fund Corp now owns 202,361 shares of the real estate investment trust’s stock worth $2,989,000 after purchasing an additional 2,706 shares during the period. SG Americas Securities LLC bought a new position in shares of Sabra Health Care REIT in the first quarter worth $1,104,000. Sei Investments Co. raised its position in shares of Sabra Health Care REIT by 1.4% in the first quarter. Sei Investments Co. now owns 109,558 shares of the real estate investment trust’s stock worth $1,618,000 after buying an additional 1,469 shares in the last quarter. Finally, US Bancorp DE grew its position in Sabra Health Care REIT by 8.3% during the first quarter. US Bancorp DE now owns 22,412 shares of the real estate investment trust’s stock worth $331,000 after buying an additional 1,713 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Health Care REIT Price Performance

Shares of Sabra Health Care REIT stock opened at $19.55 on Friday. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16. Sabra Health Care REIT, Inc. has a 52-week low of $12.83 and a 52-week high of $19.78. The company has a fifty day moving average of $18.43 and a 200-day moving average of $16.36. The stock has a market capitalization of $4.63 billion, a price-to-earnings ratio of 47.68, a price-to-earnings-growth ratio of 2.64 and a beta of 1.25.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.22). The business had revenue of $178.00 million for the quarter, compared to analysts’ expectations of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same quarter in the previous year, the company earned $0.34 earnings per share. Equities research analysts expect that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Shareholders of record on Friday, November 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.14%. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 292.69%.

Analysts Set New Price Targets

Several analysts have weighed in on the company. Citigroup raised Sabra Health Care REIT from a “neutral” rating to a “buy” rating and raised their price target for the company from $17.00 to $20.00 in a report on Friday, September 13th. Wells Fargo & Company raised shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. Scotiabank raised their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research report on Friday, October 11th. Finally, Truist Financial raised their price target on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $18.71.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.